SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Regeneron Pharmaceuticals
REGN 702.98-3.1%3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: tnsaf who wrote (577)10/12/2001 6:48:42 PM
From: Miljenko Zuanic  Read Replies (1) of 3559
 
<<TARRYTOWN, N.Y., Oct 12 (Reuters) - Regeneron Pharmaceuticals Inc. (NasdaqNM:REGN - news), which develops drugs to treat various medical conditions, said on Friday it privately sold $200 million of notes convertible into company stock, just hours after first announcing plans to sell $150 million.>>

What is going on here???

WHY NOW?????

This asks for very serious re-evaluation and immediate explanation from REGN.

Miljenko

PS: In last two years REGN have three finance with very BAD timing and very difficult market condition. Two times they did recover. This one is troubled one, for now.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext